KESIMPTA
Live / Registered — Registered — Section 71 accepted (as of 09 Oct 2024)
What this means for you
Registered since 14 Aug 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79227649
- Registration number
- 5537963
- Mark type
- Stylized text
- Filed
- 15 Jan 2018
- Published for opposition
- 29 May 2018
- Registered
- 14 Aug 2018
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: [ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; ] pharmaceutical preparations acting on the central nervous system [ ; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]
Owner
- Novartis AG, Basel, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 25 Dec 2025 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 07 Nov 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 07 Nov 2025 — INVALIDATION PROCESSED
- 18 Oct 2025 — SEC. 15 ACKNOWLEDGEMENT - E-MAILED
- 18 Oct 2025 — REGISTERED - SEC. 15 ACKNOWLEDGED
- 18 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Oct 2025 — TEAS SECTION 15 RECEIVED
- 09 Jun 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 09 Oct 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 09 Oct 2024 — REGISTERED-SEC.71 ACCEPTED
- 07 Oct 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Feb 2024 — TEAS SECTION 71 RECEIVED
- 12 Oct 2018 — NOTIFICATION PROCESSED BY IB
- 21 Sept 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 Sept 2018 — FINAL DISPOSITION PROCESSED